Alemtuzumab induces severe orbitopathy in relapsing-remitting multiple sclerosis. Rodriguez de Vera Gomez P, Mendez Muros M, Torres Cuadro A, Toyos Saenz de Miera FJ, et al. J Neurol 2023 Sep 29. doi: 10.1007/s00415-023-11995.

Read + Share

Amedeo Smart

Independent Medical Education

Rodriguez de Vera Gomez P, Mendez Muros M, Torres Cuadro A, Toyos Saenz de Miera FJ, et al. Alemtuzumab induces severe orbitopathy in relapsing-remitting multiple sclerosis. J Neurol 2023 Sep 29. doi: 10.1007/s00415-023-11995.
PMID: 37773417